Someone high up at MetLife told the SEC they plan to sell $26K of MetLife shares around Sep 18, 2026. The shares did not come from their pay.
MET · NYSE · Life & Health Insurance
Life & Health Insurance company based in New York City, New York.
Last close, Oct 1, 2026
$94.35
Adjusted for splits and dividends
Last 12 months
+15.2%
S&P 500 +14.3% over the same dates
Market value
$60B
Last close × shares outstanding
Bets against the stock: 12.3M shares sold short (1.9% of shares outstanding), +3.6% vs the previous count, 4.4 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
None
No open-market sales reported
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$77.1B
+8.6% vs the year before
Net income, fiscal 2025
$3.38B
As reported in the annual filing
Shares outstanding
635M
As of Jul 31, 2026
In fiscal 2025 the company spent $2.88B buying back its own shares and $1.51B on dividends. Cash actually paid, from its cash-flow statement.
Someone high up at MetLife told the SEC they plan to sell $26K of MetLife shares around Sep 18, 2026. The shares did not come from their pay.
Someone high up at MetLife told the SEC they plan to sell $22K of MetLife shares around Sep 18, 2026. The shares did not come from their pay.
Someone high up at MetLife told the SEC they plan to sell $4.4K of MetLife shares around Sep 18, 2026. The shares did not come from their pay.
Someone high up at MetLife told the SEC they plan to sell $2.4K of MetLife shares around Sep 18, 2026. The shares did not come from their pay.
Disclosed 116 days after the transaction; reported as an official range, not an exact amount.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Board of Directors of MetLife, Inc., as an entity
Schedule 13D: may seek to influence the company · filed Aug 6, 2026 · 102M shares
Vanguard Capital Management
Schedule 13G: passive · filed Apr 30, 2026 · 41.5M shares
Anyone owning more than 5% must file within days. Structured filings exist since December 2024, so older stakes that were never amended may be missing.
Last 12 months, adjusted daily closes
Adjusted close went from $81.93 on Oct 1, 2025 to $94.35 on Oct 1, 2026 (+15.2%). Disclosed trades in the last 12 months: 0 insider purchases, 1 insider sale, 1 Congress purchase, 0 Congress sales.
Short sale volume: 58.3% of the volume reported to FINRA over the last 20 trading days was marked short, above its 1-year average of 49.7%. FINRA daily files, to Oct 2, 2026.
Fails to deliver: 101K shares (about $9.67M) were not delivered on time for settlement on Sep 9, 2026. SEC fails-to-deliver data.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock. Fails to deliver have many causes, including processing delays, and are often resolved within days.